SCHEMBL7127422

SCHEMBL7127422

O=c1oc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 4/20 0.51
GABRD O14764 4/20 0.51
GABRA1 P14867 4/20 0.51
GABRB1 P18505 4/20 0.51
GABRG2 P18507 4/20 0.51
GABRB3 P28472 4/20 0.51
GABRA5 P31644 4/20 0.51
GABRA3 P34903 4/20 0.51
GABRA2 P47869 4/20 0.51
GABRB2 P47870 4/20 0.51
GABRA4 P48169 4/20 0.51
GABRE P78334 4/20 0.51
GABRA6 Q16445 4/20 0.51
GABRG1 Q8N1C3 4/20 0.51
GABRG3 Q99928 4/20 0.51
GABRQ Q9UN88 4/20 0.51
CA1 P00915 4/20 0.48
CA2 P00918 4/20 0.48
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7125237 0.94 CA12 (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7124757 0.92 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7122361 0.89 CA1 (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7119204 0.86 CA1 (0.62) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7120677 0.82 CA1 (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7152314 0.82 CA12 (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3091877 0.79 ERAP1 (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7807865 0.79 CA9 (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7164554 0.78 CA1 (0.61) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7165990 0.76 ESR1 (0.74) CA1CA2ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed